Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00583271 · ClinicalTrials.gov registry record
A Prospective Study of EUS Guided Celiac Block
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 127
- Enrollment target
NCT00583271: Completed study, sponsored by Indiana University.
NCT00583271 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 127 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00583271 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 127 participants
- Enrollment target
Study Summary
The purpose of this prospective study is to measure the clinical effectiveness of EUS-guided CB in subjects, 50 who have chronic pancreatitis and 50 who have pancreatic cancer, that are already undergoing celiac block for clinical reasons.
Interventions
- DRUG triamcinolone
- DRUG 98% dehydrated alcohol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 127 participants |
| Start Date | 2002-06 |
| Est. Completion | 2012-12 |
What the finished NCT00583271 record still lists
NCT00583271 is an observational study that tracks outcomes without assigning an intervention. The registered 127 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which triamcinolone is the first listed.
NCT00583271 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00583271 about?
NCT00583271 is a clinical study titled "A Prospective Study of EUS Guided Celiac Block". The purpose of this prospective study is to measure the clinical effectiveness of EUS-guided CB in subjects, 50 who have chronic pancreatitis and 50 who have pancreatic cancer, that are already undergoing celiac block for clinical reasons.
What is the current status of trial NCT00583271?
This trial is currently completed. The enrollment target is 127 participants. The study started on 2002-06. Estimated completion is 2012-12.
What interventions are being tested in trial NCT00583271?
The interventions under investigation include: triamcinolone (DRUG), 98% dehydrated alcohol (DRUG).
Who is sponsoring clinical trial NCT00583271?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03017820 · 127 participants · Phase 1
A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
- NCT03609580 · 127 participants · Phase 1
Post-operative Urinary Retention (POUR) Following Thoracic Surgery
- NCT06285643 · 127 participants · Phase 2
A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)
- NCT06809400 · 127 participants · Phase 1
A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia